MAX Chat
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.12 | -100% | 0 | 0% |
| P/S |
|
0 | 6.3 | -100% |
|
|
| P/BV |
|
0 | 1.93 | -100% |
|
|
| P/FCF |
|
0 | -73.85 | -100% |
|
|
| Ev/Ebitda |
|
0 | 1.89 | -100% |
|
|
| Ev/S |
|
0 | 15.11 | -100% |
|
|
| Ev/FCF |
|
0 | -64.17 | -100% |
|
|
| E/P |
|
0 | 0.0321 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -12.74 | -100% | 0 | 0% |
| ROE |
|
0 | 4.62 | -100% |
|
|
| ROA |
|
0 | 3.34 | -100% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
0 | 10.87 | -100% |
|
|
| ROCE |
|
0 | 0.0719 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | 0.2809 | -100% | 0 | 0% |
| Nеt Debt/Ebitda |
|
0 | -0.0221 | -100% |
|
|
| Debt/Ratio |
|
0 | 0.1341 | -100% |
|
|
| Debt/Equity |
|
0 | 0.6898 | -100% |
|
|
| Debt/Net Income |
|
0 | 2.6 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 3.92 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.23 | -100% | ||
| DSI |
|
0 | 0.5484 | -100% |
|
|
| Average dividend growth |
|
0 | -2.77 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 3.95 | -100% |
|
|
| Average percentage for payments |
|
0 | 34.06 | -100% |
|
|
| Difference from average difference in sector |
|
-3.92 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
2387.26 | -94.75 | -2619.54% | ||
| Growth impulse Ebitda in 5 years |
|
0 | -73.67 | -100% | ||
| Growth impulse Net Income in 5 years |
|
-30.76 | -111.86 | -72.5% | ||
| Growth impulse FCF in 5 years |
|
0 | -138.06 | -100% | ||
| Growth impulse EPS in 5 years |
|
-30.71 | -139.77 | -78.03% |
IP Score
2.9/10
